Publications by authors named "Kao Shi"

Claim this Profile
T
Targeting AKT to treat liver disease: Opportunities and challenges.
Zeping Wang, Xinyue Dou, Qiyuan Shan, Yan Ning, Jiajun Wang, Kao Shi

Biochem Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxifolin attenuates liver fibrosis by regulating the phosphorylation of NDRG1 at Thr328 hepatocyte-stellate cell cross talk.
Chuan Ding, Zeping Wang, Kao Shi, Sunan Li, Xinyue Dou

Acta Pharm Sin B· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis.
Chuan Ding, Zeping Wang, Xinyue Dou, Qiao Yang, Yan Ning, Shi Kao

Aging Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRT3: A potential therapeutic target for liver fibrosis.
Yan Ning, Xinyue Dou, Zhichao Wang, Kao Shi, Zeping Wang

Pharmacol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
with high pressure wine steaming enhanced anti-hepatic fibrosis: Possible through SIRT3-AMPK axis.
Xin Han, Yan Ning, Xinyue Dou, Yiwen Wang, Qiyuan Shan, Kao Shi

J Pharm Anal· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis